Betamethasone Dipropionate Cream For Psoriasis

Betamethasone Cream And Ointment

Creams are better for skin that is moist and weepy. Ointments are thicker and greasier, and are better for dry or flaky areas of skin.

You will usually use betamethasone skin cream or ointment once or twice a day.

The amount of cream or ointment you need to use is sometimes measured in fingertip units. This is the amount you can squeeze onto the end of your finger.

A fingertip unit of cream is generally enough to treat an area that’s twice the size of the palm of your hand.

For children, the right amount of cream or ointment depends on their age. A doctor or pharmacist can advise you.

If you are prescribed a combination cream containing betamethasone and an antibiotic, follow the instructions that come with your medicine.

How to apply cream or ointment

Do not use betamethasone skin cream or ointment at the same time as any other creams or ointments, such as a moisturiser or emollient. Wait at least 30 minutes before using any other skin product after you put on betamethasone cream or ointment.

Fire warning

A Pooled Analysis Of Randomized Controlled Phase 3 Trials Investigating The Efficacy And Safety Of A Novel Fixed Dose Calcipotriene And Betamethasone Dipropionate Cream For The Topical Treatment Of Plaque Psoriasis

Department of Dermatology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany

*Correspondence: A. Pinter. E-mail:

Department of Dermatology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany

*Correspondence: A. Pinter. E-mail:

Conflict of interest

AP, LJG, LSG and MA received honoraria as investigator in Phase III clinical trial from MC2 JS and MP are employees of MC2.

Funding sources

Trials presented herein were funded by MC2 Therapeutics, Hørsholm, Denmark.

This manuscript relates to two phase 3 studies, with the clinicaltrials.gov identifiers: NCT03308799 and NCT03802344.

What Is The Dosage For Wynzora

Apply Wynzora Cream to affected areas once daily for up to 8 weeks. Rub in gently to ensure that the plaques are saturated with the cream.

Do not use more than 100 g per week.

Discontinue therapy when control is achieved.

Do not use:

• with occlusive dressings unless directed by a healthcare provider
• on the face, groin, or axillae, or if skin atrophy is present at the treatment site

Wynzora Cream is not for oral, ophthalmic, or intravaginal use.

Recommended Reading: How To Cure Psoriasis On Hands

Topical Corticosteroid Regimens That Do Not Cause Hypothalamicpituitaryadrenal Axis Suppression

Calcipotriene/betamethasone dipropionate ointment did not suppress HPA axis function when used in a small number of patients for 4 weeks followed by 48 weeks of treatment as needed in patients with psoriasis involving 15% to 30% of the body surface area.161 Many low-potency TCS regimens have failed to produce HPA axis suppression in children with moderate to severe AD: three times daily dosing of hydrocortisone butyrate 0.1% cream for 4 weeks,162 twice-daily desonide hydrogel 0.05% for 4 weeks,163 and twice-daily fluticasone propionate lotion for 4 weeks.164

Why Is This Medication Prescribed

Betamethasone topical is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis and eczema . Betamethasone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.

Recommended Reading: Small Psoriasis Spots On Legs

Wynzora In Clinical Trials

Wynzora was approved based on the results of a Phase 3 clinical trial. The trial compared Wynzora to another topical cream with the same active ingredients. Nearly 800 people with plaque psoriasis participated. Overall, compared to the other topical cream, Wynzora improved plaque healing and reduced itching.1,2

Synergistic Effect Of Topical Cal/bdp On Imq

Consistent with a previous report, the topical application of IMQ to the ear for 6 consecutive days induced psoriasis-like lesions that featured scaling, skin thickening, and erythema . Thus, this demonstrates many features of human psoriasis.

First, we examined the optimum dose of topical Cal for treating IMQ-induced psoriasis-like dermatitis in mice, because the structure of mouse skin differs from that of human skin . Topical Cal significantly suppressed the IMQ-induced ear thickness in a dose-dependent manner . When Cal was applied at 2.0 nmol for 6 consecutive days, ear thickness showed maximal and significant reduction, but significant weight loss was observed . Therefore, the dose of Cal at 0.6 nmol, which was effective without causing weight loss, was set when examining its combined effect with BDP.

Figure 1

The optimal dose of topical Cal in mice with IMQ-induced psoriasis-like dermatitis. Mice received topical application of IMQ cream on the ear for 6 consecutive days, and were treated with 0.02, 0.06, 0.2, 0.6, and 2 nmol of Cal 1h before IMQ application. Normal mice were used as a negative control. Ear thickness was measured every day. Body weight was measured every three days during the experiment. The values and vertical bar represent the mean±SE of 4 mice. *p< 0.05, **p< 0.01, ***p< 0.001 vs. vehicle group by Dunnett test among the vehicle, Cal, BDP, and Cal/BDP groups.

Figure 2

You May Like: Does Shaving Your Head Help Scalp Psoriasis

The Combination Of Calcipotriol And Betamethasone Dipropionate

Calcipotriol/betamethasone dipropionate ointment and gel combine the pharmacological effects of calcipotriol and betamethasone dipropionate. The combination of the two medications has a specially designed formulation that works to both reduce inflammation and to treat the scaling associated with psoriasis.

• The calcipotriol in calcipotriol/betamethasone dipropionate ointment and gel treats the overactive skin cells.
• The betamethasone dipropionate relieves redness, swelling, itching, and irritation of the skin.
• The combination treatment flattens psoriasis plaques, removing scaling, and reducing discomfort.
• In combination, calcipotriol and betamethasone dipropionate promote greater anti-inflammatory and anti-proliferative effects than either component alone.

Common Questions About Betamethasone

Betamethasone is a steroid . Steroids help to reduce inflammation in the skin .

Skin gets inflamed when an allergic reaction or irritation causes chemicals to be released in the skin. These make your blood vessels widen and your irritated skin becomes red, swollen, itchy and painful.

Betamethasone skin treatments work on your skin’s cells to stop these chemicals being released. This reduces any swelling, redness and itching.

Your skin should start to get better after using betamethasone for a few days.

If you’re using cream, ointment or lotion, speak to your doctor if there is no improvement after 4 weeks, or if your skin gets worse at any time.

Ask your doctor how long it should take to show an improvement if you are using the scalp foam or are using betamethasone on your face. They will tell you what to do if it does not work.

For long-term skin problems, such as eczema or psoriasis, you may need to use the skin treatments for a week or two, or sometimes for longer.

To reduce the risk of side effects, your doctor may recommend that you only use betamethasone skin treatments for a few weeks at a time or for a day or two each week. Tell your doctor if your skin gets worse or does not improve within 2 to 4 weeks.

Once your skin is better, you can use moisturisers to keep it from becoming inflamed again.

If you have been using betamethasone for a long time, your doctor may tell you to gradually reduce the amount you use before stopping completely.

• mild
• very potent

Also Check: Psoriasis En Los Pies Fotos

What Are The Contraindications For Use Of Calcipotriol/betamethasone Dipropionate Ointment And Gel

The main contraindication to calcipotriol/betamethasone dipropionate ointment and gel is hypersensitivity to the active substance or to any of the excipients .

It should not be used for acute types of psoriasis such as generalisedpustular psoriasis or erythrodermic psoriasis.

Calcipotriol/betamethasone dipropionate ointment and gel should also not be used on the face or skin folds, or for skin affected with:

• is breastfeeding or plans to breastfeed .

Calcipotriene/betamethasone Dipropionate Foam Shows Long

Disclosures: We were unable to process your request. Please try again later. If you continue to have this issue please contact .

A twice-weekly dose of topical calcipotriene and betamethasone dipropionate increased the time in plaque psoriasis remission in the phase 3 PSO-LONG trial, according to a study published in Journal of the American Academy of Dermatology.

The 52-week, randomized, double-blind, maintenance phase trial assessed the long-term efficacy and safety of proactive psoriasis management with twice-weekly calcipotriene 0.005%/betamethasone dipropionate 0.064% foam.

Subjects who had achieved treatment success in a 4-week open-label lead-in phase were enrolled in the maintenance phase of the trial. They were then randomly assigned 1:1 to receive twice-weekly treatment or vehicle foam for 52 weeks.

In the treatment group, the estimated median time to first relapse was prolonged by 26 days compared with those in the vehicle group, 56 days vs. 30 days.

Relapse risk was reduced by 43% in the treatment group .

Thirty patients in the treatment group and six patients in the vehicle group did not have a relapse during the maintenance phase.

Subjects in the treatment group experienced significantly more days in remission over the year compared with the those in the vehicle group, with an estimated treatment difference of 11% , or 41 extra days in remission.

Recommended Reading: What Does Psoriasis On The Skin Look Like

Topical Calcipotriol/betamethasone Dipropionate For Psoriasis Vulgaris: A Systematic Review

Correspondence Address

Abstract

Keywords:

INTRODUCTION

Psoriasis is a common, chronic inflammatory cutaneous disease that affects 1-3% of the world population. The pathogenesis is multifactorial and there are various triggering factors. It may lead to a low quality of life and reduces physical and mental functioning. Psoriasis vulgaris is the most common form of psoriasis. Mild to moderate psoriasis vulgaris is usually treated topically with agents that may include vitamin D derivatives and corticosteroids.

Calcipotriol and betamethasone dipropionate have been used as topical therapies in psoriasis vulgaris for many years. ,, Treatments are often used in combination to improve symptom control and tolerability. It was postulated that a combination of topical calcipotriol and corticosteroid may have an additive or synergistic treatment effect due to their different mechanisms of action. This is expected to be more efficacious and better tolerated than monotherapy with either drug. However, calcipotriol and corticosteroids are usually not compatible because of their different pH requirements.

Materials and Methods

Eligibility criteria

Search strategy

Study selection and data extraction

Quality assessment

Outcome measures

Data analysis and statistical methods

RESULTS

What Should I Know About Storage And Disposal Of This Medication

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture . Do not freeze it..

It is important to keep all medication out of sight and reach of children as many containers are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location â one that is up and away and out of their sight and reach.

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA’s Safe Disposal of Medicines website for more information if you do not have access to a take-back program.

Also Check: How Do You Treat Plaque Psoriasis

How Long Will I Use It For

Most people only need to use betamethasone skin treatments for a short time. Stop as soon as your skin is better. Sometimes you only need to use the skin treatments for a few days.

Do not use the medicated plasters for more than 30 days.

If you’re using the scalp foam, or are using betamethasone on your face, ask your doctor or pharmacist how long to use it for.

If you’re using the cream, ointment or lotion, tell your doctor if your skin gets worse or does not improve within 2 to 4 weeks .

Children must not use the scalp application or foam for more than 5 to 7 days .

Cautions With Other Medicines

It’s very unlikely that other medicines will affect the way betamethasone skin treatments work.

If you’re also using any other skin treatment, make sure you wait about 30 minutes between using betamethasone and using the other skin treatment.

Tell a pharmacist or doctor if you’re taking:

• medicines used to treat HIV, such as ritonavir or cobicistat
• medicines used to treat fungal infections, such as itraconazole
• other medicines that contain steroids, such as eczema creams, asthma inhalers, tablets, injections, nasal spray, and eye or nose drops

Also Check: Get Rid Of Psoriasis For Good

Treatment Of Scalp Psoriasis With Betamethasone Dipropionate And Calcipotriol Two

Nicoletta Cassano and Gino A. Vena*

Accepted September 11, 2006.

1This study was presented as a poster at the 1st World Psoriasis & Psoriatic Arthritis Conference 2006, Stockholm 31 May4 June 2006.

Sir,

We read with interest the article of Dr Downs reporting the fast and good response of scalp psoriasis to a two-compound ointment containing 0.5 mg/g betamethasone dipropionate and 50 µ/g calcipotriol . We report here the results of a 12-week open-labelled study that aimed to evaluate the efficacy and tolerability of treatment with Dovobet ointment followed by a maintenance treatment with calcipotriol solution in scalp psoriasis.

MATERIALS AND METHODS

Twenty-five patients entered the study, after giving written informed consent. They presented with scalp psoriasis alone or associated with stable localized lesions of plaque psoriasis that were adequately controlled by topical therapies. Patients were asked to avoid treatments that interfered with study evaluations . Topical treatments for scalp psoriasis and standard systemic therapies were to be stopped for at least 2 and 4 weeks, respectively, prior to study entry.

At week 12, patients assessed both the efficacy and cosmetic acceptability of the treatment regimen using a 4-point scale from poor to excellent.

RESULTS

All patients completed the study as scheduled. At baseline, mean total score was 8.3. A significant improvement of signs and symptoms was observed at week 2 , at week 6 and week 12 .

What Is The Most Important Information I Should Know About Betamethasone Topical

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

• adrenal gland problems or
• any type of skin infection.

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant.

It may not be safe to breast-feed a baby while you are using this medicine. Ask your doctor about any risks. If you apply betamethasone to your chest, avoid areas that may come into contact with the baby’s mouth.

Do not use betamethasone topical on a child without a doctor’s advice. Children can absorb larger amounts of this medicine through the skin and may be more likely to have side effects.

Diprolene is not approved for use by anyone younger than 13 years old. Sernivo and Luxiq are not approved for anyone younger than 18 years old.

Read Also: How Do You Treat Psoriasis Of The Skin

Is Wynzora Safe To Use While Pregnant Or Breastfeeding

• Available data with Wynzora Cream are not sufficient to evaluate a drug-associated risk for major birth defects, miscarriages, or adverse maternal or fetal outcomes.
• Although there are no available data on use of the calcipotriene component in pregnant women, systemic exposure to calcipotriene after topical administration of Wynzora Cream is likely to be low.
• There is no information regarding the presence of topically administered calcipotriene and betamethasone dipropionate in human milk, the effects on the breastfed infant, or the effects on milk production.
• Concentrations of calcipotriene in plasma are low after topical administration, and therefore, concentrations in human milk are likely to be low.

Joint American Academy Of Dermatologynational Psoriasis Foundation Guidelines Of Care For The Management And Treatment Of Psoriasis In Pediatric Patients

Alan Menter MDCo-Chair, … Craig A. Elmets MDCo-Chair, inJournal of the American Academy of Dermatology, 2019

Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients.

Stan K. Bardal BSc , MBA, PhD, … Douglas S. Martin PhD, in, 2011

Also Check: How Long Does Psoriasis Outbreak Last

What Are The Potential Drug Interactions Of Calcipotriol/betamethasone Dipropionate Ointment And Gel

No interaction studies have been carried out with calcipotriol/betamethasone dipropionate ointment and gel . There is no experience with concurrent use with other systemic therapy for psoriasis or with .

Calcipotriol/betamethasone dipropionate ointment should not be used concurrently with calcium or vitamin D supplements, or with drugs that enhance the systemic availability of calcium.

What Is Calcipotriol/betamethasone Dipropionate Ointment And Gel

Calcipotriol/betamethasone dipropionate ointment and gel are topical medications for the treatment of plaque psoriasis in adult patients 18 years or older . The brand names of calcipotriol/betamethasone dipropionate are Daivobet® 50/500 ointment and Daivobet® 50/500 gel. The New Zealand marketing authorisation holder is LEO Pharma. Calcipotriol is also called calcipotriene. In some countries, the brand name for the combination product is Dovobet®.

Daivobet® ointment and Daivobet® gel are available in New Zealand with a doctors prescription and are fully funded by PHARMAC.

Also Check: How Do You Get Psoriasis On The Scalp